POSTEXPOSURE PROPHYLAXIS FOR FILOVIRUS DISEASE

Clinical trials for POSTEXPOSURE PROPHYLAXIS FOR FILOVIRUS DISEASE explained in plain language.

Never miss a new study

Get alerted when new POSTEXPOSURE PROPHYLAXIS FOR FILOVIRUS DISEASE trials appear

Sign up with your email to follow new studies for POSTEXPOSURE PROPHYLAXIS FOR FILOVIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Drug trial aims to stop deadly viruses before they take hold

Prevention Terminated

This study aimed to test if a drug called obeldesivir could safely prevent Ebola or Marburg virus disease in people who had recently been exposed to these viruses. It was designed for people who had high-risk contact with an infected person or their bodily fluids. The trial was w…

Matched conditions: POSTEXPOSURE PROPHYLAXIS FOR FILOVIRUS DISEASE

Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Prevention

Last updated Mar 30, 2026 14:28 UTC

POSTEXPOSURE PROPHYLAXIS FOR FILOVIRUS DISEASE

Get alerted when new POSTEXPOSURE PROPHYLAXIS FOR FILOVIRUS DISEASE trials appear

Drug trial aims to stop deadly viruses before they take hold